{"company": {"org_id": "T000025702", "org_name_cn": "深圳信立泰药业股份有限公司", "org_short_name_cn": "信立泰", "org_name_en": "Shenzhen Salubris Pharmaceuticals Co.,Ltd.", "org_short_name_en": "Salubris", "main_operation_business": "药品、医疗器械产品的研发、生产、销售，以及专利授权许可。", "operating_scope": "　　货物及技术进出口业务(不含进口分销业务);自有物业租赁。药品的研发、技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；市场推广、营销。（以上项目不涉及外商投资准入特别管理措施，项目涉及应取得许可审批的，须凭相关审批可经营）。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）以下项目涉及应取得许可审批的，须凭相关审批文件方可经营：开发研究、生产化学原料药、粉针剂、片剂、胶囊。", "district_encode": "440304", "org_cn_introduction": "深圳信立泰药业股份有限公司的主营业务是药品、医疗器械产品的研发、生产、销售，以及专利授权许可。公司的主要产品是心血管类药物及医疗器械、头孢类抗生素及原料、骨科药物。", "legal_representative": "叶宇翔", "general_manager": "颜杰", "secretary": "杨健锋", "established_date": 910022400000, "reg_asset": 1114816535.0, "staff_num": 3596, "telephone": "86-755-83867888", "postcode": "518040", "fax": "86-755-83867338", "email": "investor@salubris.com", "org_website": "www.salubris.com", "reg_address_cn": "广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区", "reg_address_en": null, "office_address_cn": "广东省深圳市福田区深南大道6009号车公庙绿景广场主楼(B座)37层", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1252512000000, "provincial_name": "广东省", "actual_controller": "叶澄海 (42.74%)，廖清清 (14.25%)，陈志明 (1.25%)，叶宇翔，叶宇筠", "classi_name": "外资企业", "pre_name_cn": null, "chairman": "叶宇翔", "executives_nums": 15, "actual_issue_vol": 28500000.0, "issue_price": 41.98, "actual_rc_net_amt": 1140673700.0, "pe_after_issuing": 41.77, "online_success_rate_of_issue": 0.6613, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}